Specialties: Vascular access for dialysis patients, peripheral arterial occlusive disease, varicose vein surgery for lower extremities
A
New Option for Saving Lives
Cardiogenic
shock refers to a sudden decline in heart function that leaves the heart unable
to effectively pump blood, leading to a critical state where the body’s vital
organs are not getting enough blood. For patients and their families, this
condition strikes with alarming suddenness and danger, and traditional
treatments (for example, heart-strengthening medications or an intra-aortic
balloon pump) often struggle to turn the tide.
In
recent years, extracorporeal membrane oxygenation (ECMO) has become one of the
crucial tools for saving such critical patients. However, conventional
veno-arterial ECMO (VA ECMO) — while taking over the function of the heart and
lungs — can increase the burden on the left ventricle due to the strong blood
flow it delivers, potentially leading to complications like pulmonary edema
(fluid in the lungs). To address this problem, a new technique called LAVA
ECMO emerged, bringing fresh hope to patients caught in cardiogenic shock.
What
is LAVA ECMO?
LAVA
ECMO builds on traditional VA ECMO by adding an extra drainage tube that is
inserted directly into the left atrium (LA) of the heart. Through a minimally
invasive procedure, blood can be drawn simultaneously from both the right
atrium and the left atrium, then fully oxygenated by the ECMO machine before
being returned to the arteries. This is like adding a safety valve to the ECMO
system to divert pressure from the left side of the heart, dramatically
reducing the strain on that side. Because this method relieves the left heart
without requiring open-chest surgery, it also lowers the risk of complications
such as infection and bleeding. For patients, LAVA ECMO gives a desperately failing
heart room to breathe and recover — essentially holding up a protective
umbrella for the heart in the middle of the storm.
International
Research Evidence
Research
from South Korea has indicated that performing left atrial decompression at the
same time as VA ECMO support can greatly reduce early mortality in patients.
Experience in the United States has also found that after using LAVA ECMO,
patients’ cardiac pressure improves significantly in a short time, the 30-day
survival rate exceeds 50%, and complications occur less frequently. According
to current international data, timely relief of pressure on the left side of
the heart helps improve a patient’s condition and increases the chances of
survival for those in critical care.
Facing
cardiogenic shock, medical teams have several mechanical support devices to
choose from:
·
IABP (Intra-Aortic Balloon Pump):
The procedure is relatively simple, but its effect on reducing the left heart’s
workload is limited. It is more suitable for patients who are not in the most
severe condition.
·
Traditional VA ECMO:
Provides strong circulatory support, but also increases left ventricular
pressure, meaning additional measures are needed to relieve that pressure.
·
VAD (Ventricular Assist Device):
Comes in surgical and minimally invasive forms (such as the Impella device). It
can effectively unload the left ventricle’s pressure, but is extremely
expensive.
In
comparison, LAVA ECMO combines robust circulatory support with effective
left-heart pressure relief, all without requiring open-chest surgery. This
makes it especially suitable for patients in acute cardiac crisis.
Far
Eastern Memorial Hospital’s Clinical Results
Far
Eastern Memorial Hospital (FEMH) is one of the earliest medical centers in
Taiwan to introduce LAVA ECMO. We formed a dedicated cross-disciplinary team,
with core members from the Emergency Department, Cardiovascular Medicine, and
Cardiovascular Surgery working closely together. The team developed
standardized procedures, and experts are on call 24 hours a day — ready at any
time to perform left atrial decompression when needed. Over the years, we have
accumulated a wealth of clinical cases and have shared our team’s experience at
international medical conferences multiple times.
As
of the end of 2024, our hospital has successfully performed LAVA ECMO on over
80 patients, and overall treatment outcomes have improved significantly. The
30-day survival rate of these patients is nearly 50%, far higher than what is
seen with traditional treatments. Especially for patients whose shock was
triggered by an acute myocardial infarction, using LAVA ECMO led to a notable
recovery of severely impaired heart function, showing that this technique truly
helps the heart overcome a crisis. For patients who developed pulmonary edema
due to heart failure, LAVA ECMO was like rain after a long drought. In most of
these cases, once the left atrial drainage tube was placed, the fluid buildup
in the lungs quickly subsided and the patients’ breathing improved.
A
Second Chance at Life
We
have had several end-stage heart failure patients who, supported by LAVA ECMO,
successfully held on until a donor heart became available — they underwent
heart transplant and gained a new life. These cases demonstrate that LAVA ECMO
can not only stabilize a patient’s life in critical moments, but also give
those in need enough time to receive the next stage of treatment.
FEMH’s
LAVA ECMO team has worked hard to innovate and has achieved outstanding
results, earning recognition with the National Healthcare Quality Award (NHQA)
Gold Award for Outstanding Medical Care in 2024. This honor symbolizes our
determination to safeguard life, and it belongs to every patient and healthcare
provider who has battled against illness.
Finally,
for patients and their families, every moment spent waiting for recovery feels
interminable. The advent of LAVA ECMO has brought a turning point in this race
against time. From Far Eastern Memorial Hospital’s proven results to supportive
findings from international research, we firmly believe this technology can
create a turnaround for more lives. In the future, we will continue to refine
our techniques, hoping to make LAVA ECMO the guardian of even more families —
holding up an umbrella of hope in their darkest hours.
thumbnail_LAVA ECMO